Bionomics Limited (OTCMKTS:BNOEF) Short Interest Update

Bionomics Limited (OTCMKTS:BNOEFGet Rating) was the target of a large growth in short interest in August. As of August 31st, there was short interest totalling 432,700 shares, a growth of 8.3% from the August 15th total of 399,600 shares. Based on an average daily trading volume, of 22,200 shares, the days-to-cover ratio is presently 19.5 days.

Bionomics Price Performance

Shares of BNOEF stock opened at $0.04 on Monday. Bionomics has a 12-month low of $0.03 and a 12-month high of $0.13. The business has a 50 day simple moving average of $0.04 and a 200 day simple moving average of $0.04.

Bionomics Company Profile

(Get Rating)

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder.

See Also

Receive News & Ratings for Bionomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionomics and related companies with MarketBeat.com's FREE daily email newsletter.